Getein Biotech, Inc
SSE:603387.SS
8.24 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| 229.879 | 284.08 | 503.945 | 412.011 | 330.313 | 349.947 | 250.644 | 193.781 | 138.322 | 104.788 | 74.562 | 65.628 | 21.96 |
| Depreciation & Amortization
| 93.647 | 93.085 | 70.352 | 49.405 | 35.927 | 27.937 | 24.754 | 21.034 | 15.627 | 10.184 | 6.746 | 1.811 | 1.303 |
| Deferred Income Tax
| 0 | 0 | -10.323 | -1.607 | 5.197 | -1.824 | -1.345 | -1.381 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 1.631 | 4.077 | 10.99 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 51.821 | -66.168 | -120.223 | -38.265 | -175.062 | -147.244 | -73.853 | -17.943 | 3.42 | -4.148 | 2.901 | 0 | 0 |
| Accounts Receivables
| 23.657 | -2.451 | -111.248 | -49.521 | -200.286 | -163.866 | -62.488 | -16.611 | -10.592 | 0 | 0 | 0 | 0 |
| Inventory
| 3.899 | 17.342 | -52.247 | -43.268 | -40.263 | -35.795 | -63.373 | -13.619 | -9.381 | -20.17 | -6.173 | 0 | 0 |
| Accounts Payables
| 0 | -81.06 | 53.595 | 56.132 | 60.289 | 54.241 | 53.352 | 13.667 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 24.265 | 0 | -10.323 | -1.607 | 5.197 | -1.824 | -10.48 | -4.325 | 12.802 | 16.022 | 9.075 | 0 | 0 |
| Other Non Cash Items
| 47.65 | 22.224 | 28.884 | 9.213 | -12.537 | -7.161 | -14.447 | -4.958 | -1.455 | 10.905 | 14.325 | -65.628 | -21.96 |
| Operating Cash Flow
| 422.998 | 333.221 | 482.958 | 432.365 | 185.469 | 225.733 | 187.098 | 191.913 | 155.915 | 121.729 | 98.535 | 59.716 | 23.799 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -156.402 | -258.128 | -217.444 | -179.597 | -113.533 | -124.815 | -110.744 | -61.351 | -39.315 | -46.647 | -70.089 | -12.023 | -10.39 |
| Acquisitions Net
| 1.577 | 27.721 | 15.878 | 2.871 | -54.054 | 133.503 | 4.277 | 1.8 | 39.315 | 6.186 | -6.987 | 12.023 | 0 |
| Purchases Of Investments
| -898.053 | -433.457 | -1,026.556 | -132.417 | -120.796 | -84.857 | -264.47 | -468.06 | -49.18 | -70.152 | -21.08 | -37.05 | 0 |
| Sales Maturities Of Investments
| 773.763 | 313.658 | 478.989 | 56.809 | 45.503 | 462.741 | 35.122 | 9.249 | 6.215 | 3.73 | 5.335 | 0.904 | 0 |
| Other Investing Activites
| -69.002 | -6.622 | -11.307 | -2.297 | 4.165 | -124.815 | -9.7 | 0.886 | -39.315 | -46.647 | -70.089 | -12.023 | 0.457 |
| Investing Cash Flow
| -348.118 | -356.827 | -760.44 | -254.632 | -238.714 | 261.756 | -345.516 | -519.277 | -82.28 | -106.883 | -92.821 | -48.169 | -9.933 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| -78.697 | 73.443 | 90.502 | 118.866 | 269.977 | 95 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 50.381 | 0.542 | 0.535 | 58.947 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | -50.381 | -0.542 | -0.535 | -0.654 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -110.979 | -219.405 | -123.166 | -93.161 | -104.152 | -76.265 | -59.8 | -68.169 | -59.276 | -9.381 | -11.175 | -21 | 0 |
| Other Financing Activities
| -23.989 | 0.086 | -13.218 | 6.158 | 45.851 | 8.783 | 58.293 | 671.01 | 0.1 | -2.301 | 3.128 | 0 | 1.05 |
| Financing Cash Flow
| -213.665 | -145.876 | -45.882 | -28.926 | 200.005 | 25.935 | -1.507 | 602.841 | -59.176 | -11.682 | -8.047 | -21 | 1.05 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 5.893 | 11.671 | 19.2 | -1.022 | -6.043 | 0.812 | 1.312 | -0.708 | 0.37 | 0.065 | -0.002 | 0 | 0 |
| Net Change In Cash
| -132.893 | -157.811 | -304.164 | 147.784 | 140.716 | 514.237 | -158.613 | 274.77 | 14.829 | 3.23 | -2.335 | -9.453 | 14.916 |
| Cash At End Of Period
| 350.283 | 483.176 | 640.987 | 945.151 | 797.367 | 656.65 | 142.414 | 301.027 | 26.257 | 11.428 | 8.198 | 10.534 | 19.987 |